CervoMed Inc. Net Income Loss

• CervoMed Inc. showed a decrease of -65.5% in Net Income Loss from 2024 to 2025.
• This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: -$1.84 million | Q3 2010: -$1.83 million | Q2 2011: -$2.15 million | Q3 2011: -$4.34 million | Q2 2012: -$1.32 million | Q3 2012: -$3.46 million | Q2 2013: $2.35 million | Q3 2013: -$1.53 million | Q1 2015: -$1.24 million | Q2 2015: -$1.33 million | Q3 2015: -$1.42 million | Q1 2016: -$6.22 million | Q2 2016: -$3.81 million | Q3 2016: -$5.44 million | Q1 2017: -$28.64 million | Q2 2017: $20.39 million | Q3 2017: $5.10 million | Q1 2018: -$3.31 million | Q2 2018: -$2.77 million | Q3 2018: -$6.72 million | Q1 2019: -$2.75 million | Q2 2019: -$2.50 million | Q3 2019: -$2.80 million | Q1 2020: -$2.56 million | Q2 2020: -$3.13 million | Q3 2020: -$4.44 million | Q1 2021: -$4.64 million | Q2 2021: -$3.78 million | Q3 2021: -$12.20 million | Q1 2022: -$4.53 million | Q2 2022: -$4.19 million | Q3 2022: -$882.6 thousand | Q1 2023: -$534.3 thousand | Q2 2023: -$1.43 million | Q3 2023: $2.15 million | Q1 2024: -$2.51 million | Q2 2024: -$2.32 million | Q3 2024: -$4.75 million | Q1 2025: -$4.89 million | Q2 2025: -$6.26 million | Q3 2025: -$7.73 million.
• Over the full 15 years of available data (2010 to 2025), CervoMed Inc.'s Net Income Loss has declined by 220.7%.
• Historical annual values: Fiscal year 2025: -$26.97 million | Fiscal year 2024: -$16.29 million | Fiscal year 2023: -$2.17 million | Fiscal year 2022: -$5.80 million | Fiscal year 2021: -$24.10 million | Fiscal year 2020: -$14.19 million | Fiscal year 2019: -$11.80 million | Fiscal year 2018: -$18.37 million | Fiscal year 2017: -$1.36 million | Fiscal year 2016: -$18.04 million | Fiscal year 2015: -$6.72 million | Fiscal year 2014: -$14.35 million | Fiscal year 2013: -$2.46 million | Fiscal year 2011: -$15.84 million | Fiscal year 2010: -$8.41 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026